Alpha 2.0
Login Register
» Articles » PMID: 4217320

The Effect of Mucin-containing Artificial Saliva on Severe Xerostomia

Overview
Journal Int J Oral Surg
Specialty General Surgery
Date 1974 Jan 1
PMID 4217320
Citations 9
Authors
P A ROUKEMA
A K Panders
Affiliations
Soon will be listed here.
Citing Articles

Recombinant mucin biotechnology and engineering.

Park S, Kuo J, Reesink H, Paszek M Adv Drug Deliv Rev. 2022; 193:114618.

PMID: 36375719 PMC: 10253230. DOI: 10.1016/j.addr.2022.114618.

Biopolymeric Mucin and Synthetic Polymer Analogs: Their Structure, Function and Role in Biomedical Applications.

Authimoolam S, Dziubla T Polymers (Basel). 2019; 8(3).

PMID: 30979166 PMC: 6432556. DOI: 10.3390/polym8030071.

Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers.

Vissink A, Mitchell J, Baum B, Limesand K, Jensen S, Fox P Int J Radiat Oncol Biol Phys. 2010; 78(4):983-91.

PMID: 20970030 PMC: 2964345. DOI: 10.1016/j.ijrobp.2010.06.052.

[Xerostomia. Improved care using a spray with herbal polysaccharides].

Momm F, Messmer M, Kirste S, Becker G HNO. 2010; 58(7):680-5.

PMID: 20607508 DOI: 10.1007/s00106-010-2084-z.

A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact.

Jensen S, Pedersen A, Vissink A, Andersen E, Brown C, Davies A Support Care Cancer. 2010; 18(8):1061-79.

PMID: 20333412 DOI: 10.1007/s00520-010-0837-6.